Cargando…
Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage
Currently three bona fide dendritic cell (DC) types are distinguished in human blood. Herein we focus on type 2 DCs (DC2s) and compare the three defining markers CD1c, CD172, and CD301. When using CD1c to define DC2s, a CD14(+) and a CD14(−) subset can be detected. The CD14(+) subset shares features...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554627/ https://www.ncbi.nlm.nih.gov/pubmed/33101275 http://dx.doi.org/10.3389/fimmu.2020.559166 |
_version_ | 1783593818920058880 |
---|---|
author | Heger, Lukas Hofer, Thomas P. Bigley, Venetia de Vries, I. Jolanda M. Dalod, Marc Dudziak, Diana Ziegler-Heitbrock, Loems |
author_facet | Heger, Lukas Hofer, Thomas P. Bigley, Venetia de Vries, I. Jolanda M. Dalod, Marc Dudziak, Diana Ziegler-Heitbrock, Loems |
author_sort | Heger, Lukas |
collection | PubMed |
description | Currently three bona fide dendritic cell (DC) types are distinguished in human blood. Herein we focus on type 2 DCs (DC2s) and compare the three defining markers CD1c, CD172, and CD301. When using CD1c to define DC2s, a CD14(+) and a CD14(−) subset can be detected. The CD14(+) subset shares features with monocytes, and this includes substantially higher expression levels for CD64, CD115, CD163, and S100A8/9. We review the current knowledge of these CD1c(+)CD14(+) cells as compared to the CD1c(+)CD14(−) cells with respect to phenotype, function, transcriptomics, and ontogeny. Here, we discuss informative mutations, which suggest that two populations have different developmental requirements. In addition, we cover subsets of CD11c(+)CD8(−) DC2s in the mouse, where CLEC12A(+)ESAM(low) cells, as compared to the CLEC12A(−)ESAM(high) subset, also express higher levels of monocyte-associated markers CD14, CD3, and CD115. Finally, we summarize, for both man and mouse, the data on lower antigen presentation and higher cytokine production in the monocyte-marker expressing DC2 subset, which demonstrate that the DC2 subsets are also functionally distinct. |
format | Online Article Text |
id | pubmed-7554627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75546272020-10-22 Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage Heger, Lukas Hofer, Thomas P. Bigley, Venetia de Vries, I. Jolanda M. Dalod, Marc Dudziak, Diana Ziegler-Heitbrock, Loems Front Immunol Immunology Currently three bona fide dendritic cell (DC) types are distinguished in human blood. Herein we focus on type 2 DCs (DC2s) and compare the three defining markers CD1c, CD172, and CD301. When using CD1c to define DC2s, a CD14(+) and a CD14(−) subset can be detected. The CD14(+) subset shares features with monocytes, and this includes substantially higher expression levels for CD64, CD115, CD163, and S100A8/9. We review the current knowledge of these CD1c(+)CD14(+) cells as compared to the CD1c(+)CD14(−) cells with respect to phenotype, function, transcriptomics, and ontogeny. Here, we discuss informative mutations, which suggest that two populations have different developmental requirements. In addition, we cover subsets of CD11c(+)CD8(−) DC2s in the mouse, where CLEC12A(+)ESAM(low) cells, as compared to the CLEC12A(−)ESAM(high) subset, also express higher levels of monocyte-associated markers CD14, CD3, and CD115. Finally, we summarize, for both man and mouse, the data on lower antigen presentation and higher cytokine production in the monocyte-marker expressing DC2 subset, which demonstrate that the DC2 subsets are also functionally distinct. Frontiers Media S.A. 2020-09-30 /pmc/articles/PMC7554627/ /pubmed/33101275 http://dx.doi.org/10.3389/fimmu.2020.559166 Text en Copyright © 2020 Heger, Hofer, Bigley, de Vries, Dalod, Dudziak and Ziegler-Heitbrock http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Heger, Lukas Hofer, Thomas P. Bigley, Venetia de Vries, I. Jolanda M. Dalod, Marc Dudziak, Diana Ziegler-Heitbrock, Loems Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage |
title | Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage |
title_full | Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage |
title_fullStr | Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage |
title_full_unstemmed | Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage |
title_short | Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage |
title_sort | subsets of cd1c(+) dcs: dendritic cell versus monocyte lineage |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554627/ https://www.ncbi.nlm.nih.gov/pubmed/33101275 http://dx.doi.org/10.3389/fimmu.2020.559166 |
work_keys_str_mv | AT hegerlukas subsetsofcd1cdcsdendriticcellversusmonocytelineage AT hoferthomasp subsetsofcd1cdcsdendriticcellversusmonocytelineage AT bigleyvenetia subsetsofcd1cdcsdendriticcellversusmonocytelineage AT devriesijolandam subsetsofcd1cdcsdendriticcellversusmonocytelineage AT dalodmarc subsetsofcd1cdcsdendriticcellversusmonocytelineage AT dudziakdiana subsetsofcd1cdcsdendriticcellversusmonocytelineage AT zieglerheitbrockloems subsetsofcd1cdcsdendriticcellversusmonocytelineage |